Ignite Creation Date:
2025-12-24 @ 5:10 PM
Ignite Modification Date:
2025-12-27 @ 9:28 AM
Study NCT ID:
NCT05056350
Status:
RECRUITING
Last Update Posted:
2025-02-12
First Post:
2021-09-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Professional Life After Breast Cancer: Feasibility of a Coaching Program for an Adapted Return to Work
Sponsor:
Institut du Cancer de Montpellier - Val d'Aurelle
Organization:
Study Overview
Official Title:
Professional Life After Breast Cancer: Feasibility of a Coaching Program for an Adapted Return to Work
Status:
RECRUITING
Status Verified Date:
2025-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
VISIBILITE
Brief Summary:
The diagnosis of breast cancer and the treatments implemented have a significant impact on the professional situation.
Maintaining employment and/or reintegration into working life are therefore major issues for cancer patients.
This trial proposes to study the feasibility of a support/coaching program for a return to work in patients after breast cancer.
Maintaining employment and/or reintegration into working life are therefore major issues for cancer patients.
This trial proposes to study the feasibility of a support/coaching program for a return to work in patients after breast cancer.
Detailed Description:
This study involves patients with breast cancer at the end of their adjuvant treatment.
The aim of this study is to evaluate the feasibility of a support program for an adapted return to work of these patients.
This back-to-work support program including an individual interview to identify patient needs and expectations, 7 coaching workshops (every 3 weeks +/- 15 days) and a final individual assessment post workshops.
The evolution of quality of life, psychological distress and perceptions concerning work will also be evaluated through assessments and questionnaires before (inclusion) and after the support program \[1 month (+/- 7 days) and 6 months (+/- 1 month) after the final individual assessment\].
The study also aims to estimate the recruitment rate in the study and to assess the satisfaction of this support program.
Finally, the impact of this support program on the return to work will be described.
This initial study will eventually lead to a larger research protocol on the effectiveness of the program, using a randomized controlled trial design.
The aim of this study is to evaluate the feasibility of a support program for an adapted return to work of these patients.
This back-to-work support program including an individual interview to identify patient needs and expectations, 7 coaching workshops (every 3 weeks +/- 15 days) and a final individual assessment post workshops.
The evolution of quality of life, psychological distress and perceptions concerning work will also be evaluated through assessments and questionnaires before (inclusion) and after the support program \[1 month (+/- 7 days) and 6 months (+/- 1 month) after the final individual assessment\].
The study also aims to estimate the recruitment rate in the study and to assess the satisfaction of this support program.
Finally, the impact of this support program on the return to work will be described.
This initial study will eventually lead to a larger research protocol on the effectiveness of the program, using a randomized controlled trial design.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
Secondary ID Infos
| Secondary ID | Type | Domain | Link | View |
|---|---|---|---|---|
| 2020-A00955-34 | OTHER | ID RCB number of competent autority in France | View |